Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of Cenobamate in Japanese patients with partial onset seizures
NCT06590896Phase 2Recruiting
- Sponsor
- Ono Pharmaceutical
- Start
- Nov 2022
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cenobamate in focal onset seizure, sponsored by Ono Pharmaceutical. Started Nov 2022; status: recruiting.
02
Drugs
cenobamate
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT06590896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06590896.